Clinical trials evaluating transcatheter mitral valve interventions for severe mitral regurgitation (MR) are complex. The Mitral Valve Academic Research Consortium has provided a 2-part document with recommendations related to diagnosis of MR, patient selection for trials, trial designs and endpoint definitions that are instrumental for the evaluation of all treatments related to severe MR.
You are here:
Clinical Trial Design Principles and Endpoint Definitions for Transcatheter Mitral Valve Repair and Replacement: Part 1: Clinical Trial Design Principles: A Consensus Document From the Mitral Valve Academic Research Consortium
Source: European Heart Journal
Source URL: http://www.ncbi.nlm.nih.gov/pubmed/26170467
Keywords:
Author(s): Stone GW, Vahanian AS, Adams DH, Abraham WT, Borer JS, Bax JJ, Schofer J, Cutlip DE, Krucoff MW, Blackstone EH, Généreux P, Mack MJ, Siegel RJ, Grayburn PA, Enriquez-Sarano M, Lancellotti P, Filippatos G, Kappetein AP; Mitral Valve Academic Research Consortium (MVARC)
